-
SANOFI-AVENTIS U.S. LLC et al v. FRESENIUS KABI USA, LLC DC CAFC
- 3:14-cv-07869
- D.N.J.
- Judge: Michael A. Shipp
+1
- Filed: 12/17/2014
- Closed: 03/05/2018
- Latest Docket Entry: 12/06/2019
- PACER
- Docket updated daily
4
Plaintiffs
1
Defendant
1
Accused
Product
2
Patents-in-Suit
1,175
Days in
Litigation
-
SANOFI-AVENTIS U.S. LLC et al v. FRESENIUS KABI USA, LLC DC CAFC
- 3:14-cv-07869
- D.N.J.
- Judge: Michael A. Shipp
+1
- Filed: 12/17/2014
- Closed: 03/05/2018
- Latest Docket Entry: 12/06/2019
- PACER
- Docket updated daily
Assigned Judge
Outcome Summary
- Patent Information
-
Validity & Enforceability
| Claim # | Claim Text | Outcome |
|---|---|---|
| 1 |
4.alph a.-Acetoxy-2.alpha.-benzoyloxy-5.beta.,20-epoxy-1.beta.-hydroxy-7.beta.,10.beta.-dimethoxy-9-oxo-11-taxen-13.alpha.-yl(2R,3S)-3-tert-butoxycarbonylamino-2-hydroxy-3-phenylpropionate.
|
Valid (101 and 103)
Entry 27 Entry 306 |
| 2 |
A pharmaceutical composition comprising at least the product according to claim 1 in combination with one or more pharmaceutically acceptable diluents or adjuvants and optionally one or more compatible and pharmacologically active compounds.
|
Valid (101 and 103)
Entry 27 Entry 306 |
-
Infringement
Accord Healthcare Incorporated
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Cabazitaxel Injection 60mg/1.5 mL | US 5,847,170 A |
1, 2
|
Infringement
Entry 27
|
Actavis Elizabeth LLC
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Cabazitaxel Injection 60mg/1.5 mL | US 5,847,170 A |
1, 2
|
Infringement
Entry 27
|
Actavis LLC
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Cabazitaxel Injection 60mg/1.5 mL | US 5,847,170 A |
1, 2
|
Infringement
Entry 27
|
Apotex Corporation
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Cabazitaxel Injection 60mg/1.5 mL | US 5,847,170 A |
1, 2
|
Infringement
Entry 27
|
Apotex Inc.
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Cabazitaxel Injection 60mg/1.5 mL | US 5,847,170 A |
1, 2
|
Infringement
Entry 27
|
Belcher Pharmaceuticals LLC
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Cabazitaxel Injection 60mg/1.5 mL | US 5,847,170 A |
1, 2
|
Infringement
Entry 27
|
BPI Labs LLC
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Cabazitaxel Injection 60mg/1.5 mL | US 5,847,170 A |
1, 2
|
Infringement
Entry 27
|
Breckenridge Pharmaceutical, Inc.
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Cabazitaxel Injection 60mg/1.5 mL | US 5,847,170 A |
1, 2
|
Infringement
Entry 27
|
Dr. Reddy's Lab., Inc.
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Cabazitaxel Injection 60mg/1.5 mL | US 5,847,170 A |
1, 2
|
Infringement
Entry 27
|
Dr. Reddy's Laboratories Ltd.
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Cabazitaxel Injection 60mg/1.5 mL | US 5,847,170 A |
1, 2
|
Infringement
Entry 27
|
Fresenius KABI USA LLC
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| 60 mg/3 mL solution (20 mg/mL) Cabazitaxel InjectionCabazitaxel Injection 60mg/1.5 mL | US 5,847,170 A |
1, 2
|
Infringement
Entry 27Entry 306 |
Glenmark Pharmaceuticals SA
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Cabazitaxel Injection 60mg/1.5 mL | US 5,847,170 A |
1, 2
|
Infringement
Entry 27
|
Mylan Laboratories Limited
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Cabazitaxel Injection 60mg/1.5 mL | US 5,847,170 A |
1, 2
|
Infringement
Entry 27
|
Sandoz Inc.
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Cabazitaxel Injection 60mg/1.5 mL | US 5,847,170 A |
1, 2
|
Infringement
Entry 27
|
